What is Lexicon Pharmaceuticals's long-term debt?

Lexicon Pharmaceuticals (LXRX) reported long-term debt of $49.68M in Q1 2026.

How has Lexicon Pharmaceuticals's long-term debt changed year-over-year?

Lexicon Pharmaceuticals's long-term debt decreased by 15.3% year-over-year, from $58.64M to $49.68M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Lexicon Pharmaceuticals LXRX Long-Term Debt

Long-Term Debt at other companies

Eli LillyLLY

$39.37B+14.1%

PfizerPFE

$60.57B+5.1%

Merck & Co.MRK

$49.1B+41.1%

CytokineticsCYTK

$247.21M+169%

Zevra Therapeutics, Inc.ZVRA

$0-100%

Eton Pharmaceuticals, Inc.ETON

$18.94M-36.9%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+262%

Enterprise value$976.73M+209%

P/S14.2×+5.4×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's long-term debt?: Lexicon Pharmaceuticals (LXRX) reported long-term debt of $49.68M in Q1 2026.
How has Lexicon Pharmaceuticals's long-term debt changed year-over-year?: Lexicon Pharmaceuticals's long-term debt decreased by 15.3% year-over-year, from $58.64M to $49.68M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.